{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:50:02Z","timestamp":1791557402180,"version":"4.3.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Significant gaps in hepatitis C (HCV) care outcomes exist between women and men experiencing incarceration, yet limited data examining these differences exist in the literature. Our objective was to examine HCV care outcomes among women and men in a large urban jail.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort analysis was completed of all persons incarcerated in the New York City (NYC) jail system who completed a medical intake between 1 October 2019 and 31 December 2023. Logistic regression models were used to calculate odds ratios for women versus men at each HCV care cascade step, including on-site HCV treatment initiation. Jail length of stay, history of mental health needs, homelessness, history of substance use disorders, history of HIV, and number of prior incarcerations in the last year were incorporated into the larger model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 71 100 individuals, 7.1% were women. Women had higher rates than men of HIV (3.7% vs 2.8%), mental health needs (55.1% vs 32.0%), select substance use disorders (58.5% vs 45.8%), homelessness (23.5% vs 19.5%) (P &amp;lt; .0001), and shorter jail lengths of stay (19 days vs 30 days, P &amp;lt; .0001). Of those with active HCV seen by an HCV clinician, women had about half the odds of on-site treatment initiation of men (multivariate adjusted odds ratios [AOR] = 0.561, 95% CI = .335\u2013.925).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Women were less likely to initiate jail-based HCV treatment compared to men despite similar infection rates and greater clinical engagement. Gender-focused strategies for HCV care in carceral settings are critical for achieving equitable HCV elimination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag480","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:27:12Z","timestamp":1789756032000},"source":"Crossref","is-referenced-by-count":0,"title":["Gender Differences in Hepatitis C Care Outcomes in the New York City Jail System, 2019\u20132023: A Retrospective Cohort Study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9211-7874","authenticated-orcid":false,"given":"Raphael","family":"Simonson","sequence":"first","affiliation":[{"name":"New York City Health + Hospitals\/Correctional Health Services , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batya","family":"Koenigsberg","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals\/Correctional Health Services , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gonzalez Varela","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals\/Correctional Health Services , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wiersema","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals\/Correctional Health Services , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Akiyama","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals\/Correctional Health Services , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-4036","authenticated-orcid":false,"given":"Chibuzo U","family":"Enemchukwu","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals\/Correctional Health Services , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2026100910013731300_ciag480-B1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/hep.27978","article-title":"Toward a more accurate estimate of the prevalence of hepatitis C in the United States","volume":"62","author":"Edlin","year":"2015","journal-title":"Hepatology"},{"key":"2026100910013731300_ciag480-B2","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","article-title":"HIV, HCV, and health-related harms among women who inject drugs","volume":"69 Suppl 2","author":"Iversen","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026100910013731300_ciag480-B3","doi-asserted-by":"crossref","first-page":"108525","DOI":"10.1016\/j.drugalcdep.2021.108525","article-title":"Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington","volume":"220","author":"Corcorran","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"2026100910013731300_ciag480-B4","first-page":"S1","volume-title":"Hepatology","author":"Stead","year":"2024"},{"key":"2026100910013731300_ciag480-B5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12905-021-01470-7","article-title":"Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study","volume":"21","author":"Pearce","year":"2021","journal-title":"BMC Womens Health"},{"key":"2026100910013731300_ciag480-B6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/jvh.12628","article-title":"Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis","volume":"24","author":"Esmaeili","year":"2017","journal-title":"J Viral Hepat"},{"key":"2026100910013731300_ciag480-B7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cid\/ciz162","article-title":"Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection","volume":"70","author":"Geddes","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026100910013731300_ciag480-B8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/00333549221076546","article-title":"Hepatitis C epidemiology in a large urban jail: a changing demographic","volume":"138","author":"Hoff","year":"2023","journal-title":"Public Health Rep"},{"key":"2026100910013731300_ciag480-B9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.mcna.2015.01.009","article-title":"Prevalence and management of chronic hepatitis C virus infection in women","volume":"99","author":"Beste","year":"2015","journal-title":"Med Clin North Am"},{"key":"2026100910013731300_ciag480-B10","doi-asserted-by":"crossref","first-page":"103654","DOI":"10.1016\/j.drugpo.2022.103654","article-title":"A gender lens is needed in hepatitis C elimination research","volume":"103","author":"Larney","year":"2022","journal-title":"Int J Drug Policy"},{"key":"2026100910013731300_ciag480-B11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12954-015-0045-2","article-title":"Acquiring hepatitis C in prison: the social organisation of injecting risk","volume":"12","author":"Treloar","year":"2015","journal-title":"Harm Reduct J"},{"key":"2026100910013731300_ciag480-B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1108\/IJPH-03-2017-0012","article-title":"Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system","volume":"14","author":"Strickland","year":"2018","journal-title":"Int J Prison Health"},{"key":"2026100910013731300_ciag480-B13","doi-asserted-by":"crossref","first-page":"100185","DOI":"10.1016\/j.focus.2024.100185","article-title":"Treating hepatitis C virus infection in jails as an offset to declines in treatment activity in the community, New York City, NY, 2014\u20132020","volume":"3","author":"Chan","year":"2024","journal-title":"AJPM Focus"},{"key":"2026100910013731300_ciag480-B14","doi-asserted-by":"crossref","first-page":"100567","DOI":"10.1016\/j.eclinm.2020.100567","article-title":"The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014\u20132017","volume":"27","author":"Chan","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2026100910013731300_ciag480-B15","doi-asserted-by":"crossref","first-page":"103379","DOI":"10.1016\/j.drugpo.2021.103379","article-title":"Hepatitis C treatment as prevention in the prison setting: assessments of acceptability of treatment scale up efforts by prison correctional and health personnel","volume":"98","author":"Lafferty","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2026100910013731300_ciag480-B16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7326\/M15-0617","article-title":"Prevention of hepatitis C by screening and treatment in U.S. prisons","volume":"164","author":"He","year":"2016","journal-title":"Ann Intern Med"},{"key":"2026100910013731300_ciag480-B17","doi-asserted-by":"crossref","first-page":"ofaa263","DOI":"10.1093\/ofid\/ofaa263","article-title":"Outcomes of hepatitis C virus treatment in the New York City jail population: successes and challenges facing scale up of care","volume":"7","author":"Chan","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026100910013731300_ciag480-B18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1503\/cmaj.060760","article-title":"Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons","volume":"177","author":"Poulin","year":"2007","journal-title":"Can Med Assoc J"},{"key":"2026100910013731300_ciag480-B19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2105\/AJPH.2008.149591","article-title":"Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates","volume":"100","author":"Binswanger","year":"2010","journal-title":"Am J Public Health"},{"key":"2026100910013731300_ciag480-B20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jurban\/jth085","article-title":"Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities","volume":"81","author":"Solomon","year":"2004","journal-title":"J Urban Health"},{"key":"2026100910013731300_ciag480-B21","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2105\/AJPH.2014.301996","article-title":"Assessment of hepatitis C risk factors and infection prevalence in a jail population","volume":"104","author":"Wenger","year":"2014","journal-title":"Am J Public Health"},{"key":"2026100910013731300_ciag480-B22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/0033354916662212","article-title":"Performance of risk-based and birth-cohort strategies for identifying hepatitis C virus infection among people entering prison, Wisconsin, 2014","volume":"131","author":"Stockman","year":"2016","journal-title":"Public Health Rep"},{"key":"2026100910013731300_ciag480-B23","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/jvh.13600","article-title":"Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir\/pibrentasvir in phase 2 and 3 clinical trials","volume":"28","author":"Gane","year":"2021","journal-title":"J Viral Hepat"},{"key":"2026100910013731300_ciag480-B24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/apt.13823","article-title":"All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database","volume":"45","author":"Reddy","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2026100910013731300_ciag480-B25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/pubmed\/fdv023","article-title":"A pilot study of rapid hepatitis C virus testing in the Rhode Island department of corrections","volume":"38","author":"Beckwith","year":"2016","journal-title":"J Public Health (Bangkok)"},{"key":"2026100910013731300_ciag480-B26","doi-asserted-by":"crossref","first-page":"104251","DOI":"10.1016\/j.chiabu.2019.104251","article-title":"Typologies of adversity in childhood & adulthood as determinants of mental health & substance use disorders of adults incarcerated in US prisons","volume":"99","author":"Henry","year":"2020","journal-title":"Child Abuse Negl"},{"key":"2026100910013731300_ciag480-B27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1524838018767933","article-title":"Sexual victimization and mental illness prevalence rates among incarcerated women: a literature review","volume":"21","author":"Karlsson","year":"2020","journal-title":"Trauma Violence Abuse"},{"key":"2026100910013731300_ciag480-B28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2024.20602","article-title":"The carceral-community cascade and HCV elimination","volume":"333","author":"Akiyama","year":"2025","journal-title":"JAMA"},{"key":"2026100910013731300_ciag480-B29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0033354921999385","article-title":"COVID-19 in the New York city jail system: epidemiology and health care response, March\u2013April 2020","volume":"136","author":"Chan","year":"2021","journal-title":"Public Health Rep"},{"key":"2026100910013731300_ciag480-B30","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2105\/AJPH.92.11.1789","article-title":"The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997","volume":"92","author":"Hammett","year":"2002","journal-title":"Am J Public Health"},{"key":"2026100910013731300_ciag480-B31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/003335491412900213","article-title":"Hepatitis C seroprevalence among prison inmates since 2001: still high but declining","volume":"129","author":"Varan","year":"2014","journal-title":"Public Health Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag480\/71313938\/ciag480.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag480\/71313938\/ciag480.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:01:49Z","timestamp":1791554509000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciag480\/8828139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag480","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"ciag480"}}